Head and Neck Adenocarcinoma — Trials

Head and Neck Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 19
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03614364	Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma	unknown	Phase 2	41	Samsung Medical CenterOTHER	1	Jan 4, 2022	clinicaltrials
NCT02041260	A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting	unknown	Phase 2	43	Thomas Jefferson UniversityOTHER	1	Oct 15, 2021	clinicaltrials